The data shows a diminishing trend in the number of hospital discharges for malignant neoplasm of the prostate in Mexico from 2013 to 2023, with a sharp drop in 2020 likely due to the COVID-19 pandemic. By 2023, the number stood at 4.78 thousand discharges, reflecting a 7.29% year-on-year increase from 2022. However, over the last five years, the Compound Annual Growth Rate (CAGR) was -1.85%, illustrating a general decline.
Future trends indicate a continued decrease, with the forecasted CAGR for the next five years being -2.25%, translating into a projected decrease of 10.76% by 2028. As healthcare systems normalize post-pandemic, these trends should be monitored for potential shifts due to evolving medical technologies, improved diagnostics, and changes in healthcare policies.
